WEDNESDAY, MARCH 18

11:00am – 3:30pm: INSTITUTES
1:00 – 4:00pm: HIV PCP INSTITUTE
1:00 – 5:00pm: HIV PNC INSTITUTE
4:00 – 5:30pm: TRACK SESSIONS

THURSDAY, MARCH 19

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:20 – 2:00pm: LUNCH PLENARY
2:15 – 3:45pm: TRACK SESSIONS
4:00 – 5:30pm: TRACK SESSIONS

FRIDAY, MARCH 20

9:00 – 10:30am: PLENARY SESSION
10:45am – 12:15pm: TRACK SESSIONS
12:20 – 1:30pm: LUNCH PLENARY

This schedule is preliminary and subject to change.

  • Building the HIV Prevention Workforce: CPN Network Exchange

    Studio A

    Join this interactive session to learn about the CDC-funded national initiative, the Capacity-Building Assistance Network (CPN). This session will feature presentations from several CPN HIV capacity-building providers who deliver specialized training and customized technical assistance to strengthen HIV prevention programs, organizations, and the workforce delivering these services.

  • From Policy to Practice: Defending and Advancing LGBTQ+ Health in California

    Potomac A

    This special session will: Identify key challenges and political pressures affecting LGBTQ+ health services in California, and examine how healthcare leaders are navigating institutional and regulatory constraints; Analyze real-world strategies and best practices used by health systems and community organizations to protect, sustain, and advance LGBTQ+ affirming care across clinical, educational, and operational settings; and Apply lessons learned from diverse institutional contexts to strengthen participants’ own approaches to advocacy, policy implementation, and adaptive leadership in support of LGBTQ+ health.

  • Narrowing Care Gaps in the HIV Care Continuum

    Studio D

    Bridging care gaps in the HIV care continuum, this presentation will review current HIV epidemiology in the United States, examine gaps across the HIV care continuum, and highlight missed opportunities in diagnosis, linkage, and retention in care. The session will underscore the importance of routine HIV screening and timely engagement in care, and will discuss evidence‑based strategies—including rapid initiation and re‑initiation of antiretroviral therapy—to reduce HIV transmission through sex and help narrow persistent gaps in HIV care.

  • From Interest to Implementation: Building Sustainable LAI HIV Treatment & PrEP Programs

    Studio A

    As interest in long‑acting injectable (LAI) HIV treatment and PrEP continues to grow, many healthcare sites face real‑world challenges translating enthusiasm into sustainable programs. This peer‑to‑peer panel focuses on the practical “how” of LAI implementation, featuring external experts with hands‑on experience navigating operational workflows, site‑level decision‑making, and reimbursement considerations across medical benefit (buy‑and‑bill) and pharmacy benefit models.

  • Empowering the Community: Managing EVAF with Egrifta WR

    Studio A

    During this special sessions, attendees will: Build awareness of excess visceral abdominal fat (EVAF) and how it differs from general weight gain in people with HIV (PWH); Understand how EVAF affects physical health, emotional well-being, and quality of life; Explore tools and resources available to support PWH in managing EVAF; and Discover the therapeutic role of EGRIFTA WR™ in addressing EVAF.

  • Too Big To Fail: What’s Next for the Federal Drug Pricing Program?

    Studio B

    This session features the ADAP Advocacy Association's 340B Patient Advisory Committee convening its first meeting of the year, featuring Dr. Rory Martin of IQVIA sharing his perspectives on the 340B Drug Pricing Program. The 340B Program has increasingly been targeted for reform by lawmakers at the federal and state levels, and by the Trump Administration's push to move the program to a rebate payment model. The 340B Patient Advisory Committee will convene its next meeting during SYNC to discuss ongoing executive orders, administrative rules, legislation, and pending litigation in numerous federal district courts and appellate courts.

  • Unlocking the Potential of Long-Acting Injectable Therapies for HIV Prevention and Treatment

    Studio A

    In this transformative session, we will delve into the powerful potential of long-acting injectable (LAI) strategies to not only prevent and treat HIV but to foster deeper, more meaningful healthcare engagement. With a focus on the tangible and intangible benefits of LAI therapy, this session will equip healthcare providers with practical insights and tools to optimize patient care and health outcomes. Participants will explore the multidimensional benefits of LAI therapy, highlighting how regular clinic visits can strengthen patient-provider relationships, enhance overall well-being, and create opportunities for broader health interventions.

Accreditation, Credit, and Support

Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.

Commercial Support Acknowledgement

This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.